Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
53M
-
Shares change
-
-405K
-
Total reported value, excl. options
-
$2.19B
-
Value change
-
-$15.3M
-
Put/Call ratio
-
38.35
-
Number of buys
-
106
-
Number of sells
-
-72
-
Price
-
$41.35
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q4 2024
225 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53M shares
.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (6.57M shares), JANUS HENDERSON GROUP PLC (4.58M shares), BlackRock, Inc. (3.43M shares), BVF INC/IL (2.8M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.61M shares), VANGUARD GROUP INC (2.42M shares), CITADEL ADVISORS LLC (1.51M shares), Novo Holdings A/S (1.5M shares), Rock Springs Capital Management LP (1.47M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.42M shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.